Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CONMED CorpCNMD · Entity 4691 | Director | May 31, 2024 | June 05, 2024 |
| Forest City Realty Trust, Inc.FCEA · Entity 161862 | Director | April 16, 2018 | April 25, 2018 |
| ITRON, INC.ITRI · Entity 2773 | Director | October 01, 2026 | October 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CONMED Corp
Report date May 31, 2024 · Filed June 05, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 3,856 |
Reported balance
After 2024-05-31 transaction · row 1
1 source rowRow 1 · 2024-05-31 · Exercise / conversion · Acquired 302 · Balance 3,856 |
| Rsus (restricted Stock Units)SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2033-06-01 | Direct | 0 |
Reported balance
After 2024-05-31 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2024-05-31 · Exercise / conversion · Disposed 302 · Balance 0 F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. |
| Common StockSEC Table I · non-derivative | IndirectCoppersmith Capital Management, LLC | 0 |
Reported balance
Holding disclosure · report date 2024-05-31 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 0 F1: Mr. Lande, as a Managing Member of Coppersmith Capital Management, LLC ("Coppersmith Capital"), may be deemed the beneficial owner of the 1,630,800 shares of Common Stock, $0.01 par value ("Common Stock") beneficially owned by Coppersmith Capital, the Investment Adviser to a number of investment funds or managed accounts. Mr. Lande disclaims beneficial ownership of such Common Stock except to the extent of his pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: Mr. Lande, as a Managing Member of Coppersmith Capital Management, LLC ("Coppersmith Capital"), may be deemed the beneficial owner of the 1,630,800 shares of Common Stock, $0.01 par value ("Common Stock") beneficially owned by Coppersmith Capital, the Investment Adviser to a number of investment funds or managed accounts. Mr. Lande disclaims beneficial ownership of such Common Stock except to the extent of his pecuniary interest therein.
F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period.
Forest City Realty Trust, Inc.
Report date April 16, 2018 · Filed April 25, 2018
This filing explicitly reported no securities owned.
ITRON, INC.
Report date October 01, 2026 · Filed October 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 11,373 |
Reported balance
After 2026-10-01 transaction · row 1
1 source rowRow 1 · 2026-10-01 · Grant · Acquired 608 · Balance 11,373 F1: Reflects the grant of common stock independent members of Itron's board of directors receive quarterly as part of their annual compensation for board service. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects the grant of common stock independent members of Itron's board of directors receive quarterly as part of their annual compensation for board service.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 01, 2026 Filed Oct 5, 2026 16:48 UTC | ITRON, INC. ITRI · Entity 2773 | GrantCommon Stock | 608 | $0.00 | $0.00 |
DisclosureSEC source: 0000780571-26-000222 · form4.xml · nonDerivative · entry 1 Lande Jerome J. · CIK 0001578266 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,373 F1 · shares: Reflects the grant of common stock independent members of Itron's board of directors receive quarterly as part of their annual compensation for board service. Read SEC document |
| July 01, 2026 Filed Jul 2, 2026 18:06 UTC | ITRON, INC. ITRI · Entity 2773 | GrantCommon Stock | 621 | $0.00 | $0.00 |
DisclosureSEC source: 0000780571-26-000165 · form4.xml · nonDerivative · entry 1 Lande Jerome J. · CIK 0001578266 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,765 F1 · shares: Reflects the grant of common stock independent members of Itron's board of directors receive quarterly as part of their annual compensation for board service. Read SEC document |
| April 01, 2026 Filed Apr 2, 2026 15:51 UTC | ITRON, INC. ITRI · Entity 2773 | GrantCommon Stock | 580 | $0.00 | $0.00 |
DisclosureSEC source: 0000780571-26-000099 · form4.xml · nonDerivative · entry 1 Lande Jerome J. · CIK 0001578266 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,144 F1 · shares: Reflects the grant of common stock independent members of Itron's board of directors receive quarterly as part of their annual compensation for board service. Read SEC document |
| January 02, 2026 Filed Jan 5, 2026 20:32 UTC | ITRON, INC. ITRI · Entity 2773 | GrantCommon Stock | 529 | $0.00 | $0.00 |
DisclosureSEC source: 0000780571-26-000006 · form4.xml · nonDerivative · entry 1 Lande Jerome J. · CIK 0001578266 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,538 F1 · shares: Reflects the grant of common stock independent members of Itron's board of directors receive quarterly as part of their annual compensation for board service. Read SEC document |
| January 02, 2026 Filed Jan 9, 2026 23:02 UTC Amendment | ITRON, INC. ITRI · Entity 2773 | GrantCommon Stock | 555 | $0.00 | $0.00 |
DisclosureSEC source: 0000780571-26-000024 · form4a.xml · nonDerivative · entry 1 Lande Jerome J. · CIK 0001578266 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,564 F1 · shares: Reflects the grant of common stock independent members of Itron's board of directors receive quarterly as part of their annual compensation for board service. F2 · balance_after: This amendment is being filed to include 26 shares inadvertently omitted due to an arithmetic error. Read SEC document |
| October 01, 2025 Filed Oct 2, 2025 22:50 UTC | ITRON, INC. ITRI · Entity 2773 | GrantCommon Stock | 408 | $0.00 | $0.00 |
DisclosureSEC source: 0000780571-25-000063 · form4.xml · nonDerivative · entry 1 Lande Jerome J. · CIK 0001578266 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,009 F1 · shares: Reflects the grant of common stock independent members of Itron's board of directors receive quarterly as part of their annual compensation for board service. Read SEC document |
| July 01, 2025 Filed Jul 2, 2025 16:51 UTC | ITRON, INC. ITRI · Entity 2773 | GrantCommon Stock | 377 | $0.00 | $0.00 |
DisclosureSEC source: 0000780571-25-000027 · form4.xml · nonDerivative · entry 1 Lande Jerome J. · CIK 0001578266 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,601 F1 · shares: Reflects the grant of common stock independent members of Itron's board of directors receive quarterly as part of their annual compensation for board service. Read SEC document |
| April 01, 2025 Filed Apr 1, 2025 23:30 UTC | ITRON, INC. ITRI · Entity 2773 | GrantCommon Stock | 472 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-010847 · form4.xml · nonDerivative · entry 1 Lande Jerome J. · CIK 0001578266 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,224 F1 · shares: Reflects the grant of common stock independent members of Itron's board of directors receive quarterly as part of their annual compensation for board service. Read SEC document |
| January 02, 2025 Filed Jan 4, 2025 00:10 UTC | ITRON, INC. ITRI · Entity 2773 | GrantCommon Stock | 460 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-000563 · form4.xml · nonDerivative · entry 1 Lande Jerome J. · CIK 0001578266 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,752 F1 · shares: Reflects the grant of common stock independent members of Itron's board of directors receive quarterly as part of their annual compensation for board service. Read SEC document |
| October 01, 2024 Filed Oct 2, 2024 22:55 UTC | ITRON, INC. ITRI · Entity 2773 | GrantCommon Stock | 475 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-024991 · form4.xml · nonDerivative · entry 1 Lande Jerome J. · CIK 0001578266 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,292 F1 · shares: Reflects the grant of common stock independent members of Itron's board of directors receive quarterly as part of their annual compensation for board service. Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 20:11 UTC | ITRON, INC. ITRI · Entity 2773 | GrantCommon Stock | 509 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-019851 · form4.xml · nonDerivative · entry 1 Lande Jerome J. · CIK 0001578266 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,817 F1 · shares: Reflects the grant of common stock independent members of Itron's board of directors receive quarterly as part of their annual compensation for board service. Read SEC document |
| May 31, 2024 Filed Jun 5, 2024 01:17 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 302 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017854 · form4.xml · derivative · entry 3 Lande Jerome J. · CIK 0001578266 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 302 shares Expires 2033-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| May 31, 2024 Filed Jun 5, 2024 01:17 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 302 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017854 · form4.xml · nonDerivative · entry 1 Lande Jerome J. · CIK 0001578266 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,856 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 20:44 UTC | ITRON, INC. ITRI · Entity 2773 | GrantCommon Stock | 558 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-011856 · form4.xml · nonDerivative · entry 1 Lande Jerome J. · CIK 0001578266 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,308 F1 · shares: Reflects the grant of common stock independent members of Itron's board of directors receive quarterly as part of their annual compensation for board service. Read SEC document |
| March 07, 2024 Filed Mar 7, 2024 23:47 UTC | ITRON, INC. ITRI · Entity 2773 | SaleCommon Stock | 6,007 | $95.32 | $572,595.05 |
DisclosureSEC source: 0001127602-24-009087 · form4.xml · nonDerivative · entry 3 Lande Jerome J. · CIK 0001578266 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,750 F2 · price: Represents weighted average price. Shares were sold in multiple transactions at prices ranging from $95.2500 to $95.4600, inclusive. Reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges specified. Read SEC document |
| March 07, 2024 Filed Mar 7, 2024 23:47 UTC | ITRON, INC. ITRI · Entity 2773 | SaleCommon Stock | 3,169 | $94.68 | $300,039.65 |
DisclosureSEC source: 0001127602-24-009087 · form4.xml · nonDerivative · entry 2 Lande Jerome J. · CIK 0001578266 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,757 F1 · price: Represents weighted average price. Shares were sold in multiple transactions at prices ranging from $94.5200 to $94.8145, inclusive. Reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges specified. Read SEC document |
| March 07, 2024 Filed Mar 7, 2024 23:47 UTC | ITRON, INC. ITRI · Entity 2773 | SaleCommon Stock | 5,720 | $95.50 | $546,260.00 |
DisclosureSEC source: 0001127602-24-009087 · form4.xml · nonDerivative · entry 1 Lande Jerome J. · CIK 0001578266 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,926 Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 16:58 UTC | ITRON, INC. ITRI · Entity 2773 | GrantCommon Stock | 665 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-000693 · form4.xml · nonDerivative · entry 1 Lande Jerome J. · CIK 0001578266 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,646 F1 · shares: Reflects the grant of common stock independent members of Itron's board of directors receive quarterly as part of their annual compensation for board service. Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 17:13 UTC | ITRON, INC. ITRI · Entity 2773 | GrantCommon Stock | 701 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-025450 · form4.xml · nonDerivative · entry 1 Lande Jerome J. · CIK 0001578266 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,981 F1 · shares: Reflects the grant of common stock independent members of Itron's board of directors receive quarterly as part of their annual compensation for board service. Read SEC document |
| July 03, 2023 Filed Jul 5, 2023 21:43 UTC | ITRON, INC. ITRI · Entity 2773 | GrantCommon Stock | 578 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-020245 · form4.xml · nonDerivative · entry 1 Lande Jerome J. · CIK 0001578266 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,280 F1 · shares: Reflects the grant of common stock independent members of Itron's board of directors receive quarterly as part of their annual compensation for board service. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 21:40 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 2,826 | $0.00 Strike: $123.79 | $0.00 |
DisclosureSEC source: 0001127602-23-017624 · form4.xml · derivative · entry 4 Lande Jerome J. · CIK 0001578266 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,826 Underlying: Common Stock · 2,826 shares Expires 2033-06-01 F2 · derivative.exercise_date: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 21:40 UTC | CONMED Corp CNMD · Entity 4691 | GrantRsus (restricted Stock Units) · Derivative | 302 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-017624 · form4.xml · derivative · entry 3 Lande Jerome J. · CIK 0001578266 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 302 Underlying: Common Stock · 302 shares Expires 2033-06-01 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 21:40 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 335 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-017624 · form4.xml · derivative · entry 2 Lande Jerome J. · CIK 0001578266 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 335 shares Expires 2032-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 21:40 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 335 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-017624 · form4.xml · nonDerivative · entry 1 Lande Jerome J. · CIK 0001578266 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,554 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 03, 2023 Filed Apr 5, 2023 17:15 UTC | ITRON, INC. ITRI · Entity 2773 | GrantCommon Stock | 745 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-012505 · form4.xml · nonDerivative · entry 1 Lande Jerome J. · CIK 0001578266 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,702 F1 · shares: Reflects the grant of common stock independent members of Itron's board of directors receive quarterly as part of their annual compensation for board service. F2 · balance_after: Due to an inadvertent error in the number of shares reported on the reporting person's Form 4 filed on July 5, 2022, as amended November 10, 2022, the balance shown includes additional two shares to correct the inadvertent error. Read SEC document |
| January 03, 2023 Filed Jan 4, 2023 22:21 UTC | ITRON, INC. ITRI · Entity 2773 | GrantCommon Stock | 797 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-000595 · form4.xml · nonDerivative · entry 1 Lande Jerome J. · CIK 0001578266 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,955 F1 · shares: Reflects the grant of common stock independent members of Itron's board of directors receive quarterly as part of their annual compensation for board service. Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 19:36 UTC | ITRON, INC. ITRI · Entity 2773 | GrantCommon Stock | 937 | $44.01 | $41,237.37 |
DisclosureSEC source: 0001127602-22-023678 · form4.xml · nonDerivative · entry 1 Lande Jerome J. · CIK 0001578266 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,158 F1 · shares: Reflects the grant of common stock independent members of Itron's board of directors receive quarterly as part of their annual compensation for board service. Read SEC document |
| October 03, 2022 Filed Nov 10, 2022 16:21 UTC Amendment | ITRON, INC. ITRI · Entity 2773 | GrantCommon Stock | 937 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-025242 · form4a.xml · nonDerivative · entry 1 Lande Jerome J. · CIK 0001578266 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,158 Read SEC document |
| July 01, 2022 Filed Jul 5, 2022 17:00 UTC | ITRON, INC. ITRI · Entity 2773 | GrantCommon Stock | 851 | $48.43 | $41,213.93 |
DisclosureSEC source: 0001127602-22-018657 · form4.xml · nonDerivative · entry 1 Lande Jerome J. · CIK 0001578266 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,221 F1 · shares: Reflects the grant of common stock independent members of Itron's board of directors receive quarterly as part of their annual compensation for board service. Read SEC document |
| July 01, 2022 Filed Nov 10, 2022 16:17 UTC Amendment | ITRON, INC. ITRI · Entity 2773 | GrantCommon Stock | 851 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-025240 · form4a.xml · nonDerivative · entry 1 Lande Jerome J. · CIK 0001578266 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,221 F1 · shares: Reflects the grant of common stock independent members of Itron's board of directors receive quarterly as part of their annual compensation for board service. F2 · price: This amendment is being filed to correctly reflect the price shown in Column 4 as $0. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 01:23 UTC | CONMED Corp CNMD · Entity 4691 | GrantRsus (restricted Stock Units) · Derivative | 335 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-016539 · form4.xml · derivative · entry 4 Lande Jerome J. · CIK 0001578266 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 335 Underlying: Common Stock · 335 shares Expires 2032-06-01 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 01:23 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 3,453 | $0.00 Strike: $111.79 | $0.00 |
DisclosureSEC source: 0001127602-22-016539 · form4.xml · derivative · entry 3 Lande Jerome J. · CIK 0001578266 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,453 Underlying: Common Stock · 3,453 shares Expires 2032-06-01 F2 · derivative.exercise_date: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 01:23 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 812 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-016539 · form4.xml · derivative · entry 2 Lande Jerome J. · CIK 0001578266 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 812 shares Expires 2031-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 01:23 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 812 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-016539 · form4.xml · nonDerivative · entry 1 Lande Jerome J. · CIK 0001578266 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,219 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 17, 2022 Filed May 17, 2022 23:13 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 1,521 | $117.00 | $177,957.00 |
DisclosureSEC source: 0001127602-22-014830 · form4.xml · nonDerivative · entry 2 Lande Jerome J. · CIK 0001578266 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,407 Read SEC document |
| May 13, 2022 Filed May 17, 2022 23:13 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 6,000 | $115.42 | $692,535.60 |
DisclosureSEC source: 0001127602-22-014830 · form4.xml · nonDerivative · entry 1 Lande Jerome J. · CIK 0001578266 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,928 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.0355 to $115.50. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| April 01, 2022 Filed Apr 4, 2022 21:43 UTC | ITRON, INC. ITRI · Entity 2773 | GrantCommon Stock | 774 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-011275 · form4.xml · nonDerivative · entry 1 Lande Jerome J. · CIK 0001578266 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,370 F1 · shares: Reflects the grant of common stock independent members of Itron's board of directors receive quarterly as part of their annual compensation for board service. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 22:01 UTC | ITRON, INC. ITRI · Entity 2773 | GrantCommon Stock | 598 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-000489 · doc4.xml · nonDerivative · entry 1 Lande Jerome J. · CIK 0001578266 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,596 F1 · shares: Reflects the grant of common stock independent members of Itron's board of directors receive quarterly as part of their annual compensation for board service. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 21:24 UTC | ITRON, INC. ITRI · Entity 2773 | GrantCommon Stock | 424 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-012922 · doc4.xml · nonDerivative · entry 1 Lande Jerome J. · CIK 0001578266 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,998 F1 · shares: Reflects the grant of common stock independent members of Itron's board of directors receive quarterly as part of their annual compensation for board service. Read SEC document |
| July 01, 2021 Filed Jul 7, 2021 00:49 UTC | ITRON, INC. ITRI · Entity 2773 | GrantCommon Stock | 322 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-21-023555 · form4.xml · nonDerivative · entry 1 Lande Jerome J. · CIK 0001578266 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,574 F1 · shares: Reflects the grant of common stock independent members of Itron's board of directors receive quarterly as part of their annual compensation for board service. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 18:22 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 865 | $0.00 Strike: $138.45 | $0.00 |
DisclosureSEC source: 0001127602-21-018903 · form4.xml · derivative · entry 4 Lande Jerome J. · CIK 0001578266 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 865 Underlying: Common Stock · 865 shares Expires 2031-06-01 F2 · derivative.exercise_date: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 18:22 UTC | CONMED Corp CNMD · Entity 4691 | GrantRsus (restricted Stock Units) · Derivative | 812 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-018903 · form4.xml · derivative · entry 3 Lande Jerome J. · CIK 0001578266 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 812 Underlying: Common Stock · 812 shares Expires 2031-06-01 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 18:22 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 1,521 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-018903 · form4.xml · derivative · entry 2 Lande Jerome J. · CIK 0001578266 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,521 shares Expires 2030-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 18:22 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 1,521 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-018903 · form4.xml · nonDerivative · entry 1 Lande Jerome J. · CIK 0001578266 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,928 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 14:13 UTC | ITRON, INC. ITRI · Entity 2773 | GrantCommon Stock | 358 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-21-011527 · form4.xml · nonDerivative · entry 1 Lande Jerome J. · CIK 0001578266 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,252 F1 · shares: Reflects the grant of common stock independent members of Itron's board of directors receive quarterly as part of their annual compensation for board service. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 23:08 UTC | ITRON, INC. ITRI · Entity 2773 | GrantCommon Stock | 659 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-21-000375 · form4.xml · nonDerivative · entry 1 Lande Jerome J. · CIK 0001578266 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,894 F1 · shares: Reflects the grant of common stock independent members of Itron's board of directors receive quarterly as part of their annual compensation for board service. For the reporting person, this reported grant includes 320 shares of common stock for the pro-rated portion of the reporting person's fourth quarter 2020 service compensation. Prior to that, the reporting person waived their receipt of common stock for their annual compensation for board service. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 19:33 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 1,843 | $0.00 Strike: $73.94 | $0.00 |
DisclosureSEC source: 0001127602-20-018661 · form4.xml · derivative · entry 4 Lande Jerome J. · CIK 0001578266 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,843 Underlying: Common Stock · 1,843 shares Expires 2030-06-01 F3 · derivative.exercise_date: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 19:33 UTC | CONMED Corp CNMD · Entity 4691 | GrantRsus (restricted Stock Units) · Derivative | 1,521 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-018661 · form4.xml · derivative · entry 3 Lande Jerome J. · CIK 0001578266 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,521 Underlying: Common Stock · 1,521 shares Expires 2030-06-01 F2 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 19:33 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 1,407 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-018661 · form4.xml · derivative · entry 2 Lande Jerome J. · CIK 0001578266 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,407 shares Expires 2029-06-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represented a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and were subject to the terms and conditions of the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs otherwise generally vesting 100% after a one year period. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 19:33 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 1,407 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-018661 · form4.xml · nonDerivative · entry 1 Lande Jerome J. · CIK 0001578266 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,407 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.